Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: Immunotherapy has emerged as a promising treatment for non-small cell lung cancer (NSCLC). Yet, some patients cannot benefit from immunotherapy, and reliable biomarkers for selecting sensitive patients are needed. Herein, we performed a meta-analysis to evaluate the predictive value of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Guangxian, Liu, Xiaowei, Ma, Tian, Lv, Desheng, Sun, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812984/
https://www.ncbi.nlm.nih.gov/pubmed/35113949
http://dx.doi.org/10.1371/journal.pone.0263629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812984/
https://www.ncbi.nlm.nih.gov/pubmed/35113949
http://dx.doi.org/10.1371/journal.pone.0263629

Ejemplares similares